BEIJING, Oct. 21, 2021
/PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord
Medical" or the "Company") (NYSE: CCM), a healthcare provider
specializing in cancer care, research and prevention by operating a
network of medically advanced comprehensive cancer hospitals and
standalone radiotherapy and diagnostic imaging centers in
China, today announced that its
Guangzhou Concord Cancer Center ("GCCC"), has obtained the
qualifications of Social Healthcare Insurance designated medical
institution, allowing more patients to gain access to high quality
medical services with a lower self-paying proportion.
Supported by National Healthcare Security Administration, the
Social Healthcare Insurance system is the most important player in
the healthcare industry which covers over 95% of China's population (approximately 13.5
billion). In Guangzhou, the Social
Healthcare Insurance system can pay for up to 90% of the costs of
medical services. In addition to the Social Healthcare Insurance,
GCCC has also signed partnerships with renowned insurance
companies, with certain insurance products covering the majority of
the medical expenses at GCCC for their clients. By October, GCCC
has achieved cooperation with multiple international and domestic
commercial insurance companies.
GCCC is operated by Meizhong Jiahe Medical Science &
Technology Development Group Co., Ltd. ("Meizhong Jiahe"), a
subsidiary of Concord Medical, and is established in cooperation
with top international and domestic medical institutions.
Constructed since 2010, GCCC is now able to provide patients with
comprehensive medical services from cancer prevention to
recovery.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare
provider specialized in cancer treatment, research, education and
prevention. The Company operates a network of medically advanced
comprehensive cancer hospitals and standalone radiotherapy and
diagnostic imaging centres in China. The Company focuses on providing
multidisciplinary cancer care approach in all areas of oncology
services in its cancer hospitals. The Company also equips its
hospitals with technologically advanced equipment such as the
state-of-the-art proton therapy system in its premium cancer
hospitals in top-tier cities including Beijing, Shanghai, and Guangzhou. In addition, the Company saw the
opportunity of the expanding market of medical equipment in
China and developed its product
life-cycle management services form its existing medical equipment
and consumable sales services. As of December 31, 2020, the
Company operated a network of 27 radiotherapy centers and
diagnostic imaging centers, which are based in 20 hospitals,
established under long-term lease and management services
arrangements with the Company and spanning over 20 cities across 13
provinces and administrative regions in China. To ensure the
commitment to the highest standard of medical services for
patients, the Company offers ongoing education and training for
doctors and other medical professionals in its network hospitals
and centres in both domestic and overseas medical institutions.
Safe Harbor Statement
This announcement contains forward-looking statements. These
forward-looking statements can be identified by words or phrases
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar expressions.
Forward-looking statements are inherently subject to uncertainties
and contingencies beyond the Company's control and based upon
premises with respect to future business decisions, which are
subject to change. A number of important factors could cause actual
results to differ materially from those contained in any
forward-looking statement. The Company does not undertake any
obligation to update any forward-looking statement, except as
required under applicable law.
View original
content:https://www.prnewswire.com/news-releases/guangzhou-concord-cancer-center-becomes-a-designated-hospital-of-social-healthcare-insurance-301405305.html
SOURCE Concord Medical Services Holdings Limited